The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b trial of blood-brain barrier (BBB)-penetrant tyrosine kinase inhibitor (TKI) tesevatinib in combination with trastuzumab for patients with HER2+ metastatic breast cancer (MBC).
 
Komal L. Jhaveri
No Relationships to Disclose
 
Erika Paige Hamilton
No Relationships to Disclose
 
Kathy Miller
Consulting or Advisory Role - Clovis Oncology; ImClone Systems; Nektar
Research Funding - AVEO (Inst); BiPar Sciences (Inst); EntreMed (Inst); Genentech (Inst); Geron (Inst); ImClone Systems (Inst); Lilly (Inst); Macrogenics (Inst); Medivation (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Maria Roche
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
 
Mark S. Berger
Employment - Deciphera; Kadmon
Leadership - Deciphera; Kadmon
Stock and Other Ownership Interests - Deciphera; Kadmon
 
Eric P. Winer
Consulting or Advisory Role - Genentech/Roche; Novartis; Verastem
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Novartis
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; Geron; GlaxoSmithKline; Kadmon; Novartis